Sapir Alex
- SEC CIK
- 0001709415
No open-market purchases or sales filed in the past year.
Current role at each company
- FULC Fulcrum Therapeutics, Inc.See Remarksas of Feb 4, 2026
- PHAS PhaseBio Pharmaceuticals IncDirectoras of May 19, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sapir Alex as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FULC Fulcrum Therapeutics, Inc.
See Remarks1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 (view filing) | Mar 4 | 1 day | Sapir AlexSee Remarks | PPurchase | +43.4K | $11.35 | +$492.1K | New position43.4K after |